The groundbreaking success of Viagra undeniably revolutionized the medication landscape, but placing funds in companies heavily reliant on off-patent versions presents a challenging picture. Although early profits were impressive, the cessation of patents and the rise of discounted alternatives have weakened market share. Therefore, a thorough asse